These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8800603)

  • 1. Increases in the myocardial concentration of vasoactive intestinal peptide may explain the positive inotropic effect of angiotensin converting enzyme inhibitors.
    Ye VZ; Duggan KA
    Clin Exp Pharmacol Physiol; 1996; 23(6-7):617-8. PubMed ID: 8800603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibition with enalapril increases the cardiac concentration of vasoactive intestinal peptide.
    Duggan KA; Ye VZ
    Ann N Y Acad Sci; 1996 Dec; 805():713-6. PubMed ID: 8993466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of enalapril on vasoactive intestinal peptide metabolism and tissue levels.
    Duggan KA; Ye VZ
    Eur J Pharmacol; 1998 Sep; 358(1):25-30. PubMed ID: 9809865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in vasoactive intestinal polypeptides (VIP) by the angiotensin converting enzyme (ACE) inhibitor lisinopril in congestive heart failure. Relation to haemodynamic and hormonal changes.
    Woie L; Dickstein K; Kaada B
    Gen Pharmacol; 1987; 18(6):577-87. PubMed ID: 2822521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopeptidase inhibition reverses myocardial vasoactive intestinal peptide depletion and decreases fibrosis in salt sensitive hypertension.
    Ye VZ; Hodge G; Yong JL; Duggan KA
    Eur J Pharmacol; 2004 Feb; 485(1-3):235-42. PubMed ID: 14757146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D receptor agonist VS-105 improves cardiac function in the presence of enalapril in 5/6 nephrectomized rats.
    Wu-Wong JR; Chen YW; Wessale JL
    Am J Physiol Renal Physiol; 2015 Feb; 308(4):F309-19. PubMed ID: 25503724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of endopeptidase 24.11 inhibition on plasma and tissue concentrations of vasoactive intestinal peptide.
    Duggan KA; Jones DM; Ye VZ; Davis RE; Macdonald GJ
    Clin Sci (Lond); 1995 Sep; 89(3):267-71. PubMed ID: 7493422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent effects of angiotensin-converting enzyme inhibition and angiotensin II-receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats.
    Taylor K; Patten RD; Smith JJ; Aronovitz MJ; Wight J; Salomon RN; Konstam MA
    J Cardiovasc Pharmacol; 1998 May; 31(5):654-60. PubMed ID: 9593063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the angiotensin-converting enzyme inhibitor enalapril on sympathetic neuronal function and beta-adrenergic desensitization in heart failure after myocardial infarction in rats.
    Igawa A; Nozawa T; Yoshida N; Fujii N; Kato B; Inoue M; Tazawa S; Yamada Y; Asanoi H; Inoue H
    Jpn Heart J; 2002 Nov; 43(6):675-88. PubMed ID: 12558131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with angiotensin I-converting enzyme inhibitors attenuates the loss of cardiac beta-adrenoceptor responses in rats with chronic heart failure.
    Sanbe A; Takeo S
    Circulation; 1995 Nov; 92(9):2666-75. PubMed ID: 7586371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enalapril protects against myocardial ischemia/reperfusion injury in a swine model of cardiac arrest and resuscitation.
    Wang G; Zhang Q; Yuan W; Wu J; Li C
    Int J Mol Med; 2016 Nov; 38(5):1463-1473. PubMed ID: 27633002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a calcium-sensitizing positive inotropic agent MCI-154 and its combined use with enalapril on postischemic contractile dysfunction of dog hearts.
    Abe Y; Kitada Y; Narimatsu A
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):653-9. PubMed ID: 8569229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of neutral endopeptidase on plasma and tissue concentrations of vaso-active intestinal peptide.
    Duggan KA; Jones DM; Davis RE; Macdonald GJ
    Clin Exp Pharmacol Physiol; 1994 Apr; 21(4):307-9. PubMed ID: 7923896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibition decreases cell turnover in the neonatal rat heart.
    Choi JH; Yoo KH; Cheon HW; Kim KB; Hong YS; Lee JW; Kim SK; Kim CH
    Pediatr Res; 2002 Sep; 52(3):325-32. PubMed ID: 12193663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal peptide down-regulates the intrahepatic renin-angiotensin system in the anaesthetized rat.
    Ye VZ; Duggan KA
    Clin Sci (Lond); 2000 Sep; 99(3):201-6. PubMed ID: 11787472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
    Ocaranza MP; Godoy I; Jalil JE; Varas M; Collantes P; Pinto M; Roman M; Ramirez C; Copaja M; Diaz-Araya G; Castro P; Lavandero S
    Hypertension; 2006 Oct; 48(4):572-8. PubMed ID: 16908757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin I-converting enzyme inhibition but not angiotensin II suppression alters angiotensin I-converting enzyme gene expression in vessels and epithelia.
    Costerousse O; Allegrini J; Clozel JP; Ménard J; Alhenc-Gelas F
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1180-7. PubMed ID: 9495881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE inhibitors and cardiac ACE mRNA in volume overload-induced cardiac hypertrophy.
    Lear W; Ruzicka M; Leenen FH
    Am J Physiol; 1997 Aug; 273(2 Pt 2):H641-6. PubMed ID: 9277479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of dietary sodium on the concentrations of vasoactive intestinal peptide in plasma and lung.
    Ye VZ; Duggan KA
    Chest; 1995 Aug; 108(2):535-8. PubMed ID: 7634895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction.
    Duncan AM; Burrell LM; Kladis A; Campbell DJ
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):746-54. PubMed ID: 8961071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.